Picking a CDMO as a CGT developer: what to consider and why

<!DOCTYPE html> <html lang="en"> <head>  <script>(function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-W9C8F5F');</script>  <meta charset="UTF-8"> <title>Picking a CDMO as a CGT developer: what to consider and why</title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="theme-color" content="#FFF"> <meta name="author" content=""> <meta name="google-site-verification" content="bD4tV4Sl-EwlSwu4w1alwBUpBtTV_kAj0pkGjAarY-w"> <meta name="yandex-verification" content="52377bb9620367bb"> <meta itemprop="url" content="https://manufacturingchemist.com/"> <meta name="keywords" content=""> <meta name="description" content="Cell and gene therapy development and manufacture can be risky and highly complex, so biopharma companies would benefit from investing in a reliable and experienced CDMO"> <link rel="icon" type="image/ico" href="/favicon.ico"> <link rel="canonical" href="https://manufacturingchemist.com/charles-river-laboratories-picking-a-cdmo-as-a-cell-gene-therapy-developer" /> <meta property="og:url" content="https://manufacturingchemist.com/charles-river-laboratories-picking-a-cdmo-as-a-cell-gene-therapy-developer"> <meta property="og:title" content="Picking a CDMO as a CGT developer: what to consider and why"> <meta property="og:description" content="Cell and gene therapy development and manufacture can be risky and highly complex, so biopharma companies would benefit from investing in a reliable and experienced CDMO"> <meta property="og:image" content="/article-image-alias/picking-a-cdmo-as-a-cgt-3.jpg"> <meta property="og:image:alt" content="Picking a CDMO as a CGT developer: what to consider and why"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="manchempharma"> <meta name="twitter:creator" content="@hpcimedia"> <meta name="twitter:title" content="Picking a CDMO as a CGT developer: what to consider and why"> <meta name="twitter:description" content="Cell and gene therapy development and manufacture can be risky and highly complex, so biopharma companies would benefit from investing in a reliable and experienced CDMO"> <meta name="twitter:image" content="/article-image-alias/picking-a-cdmo-as-a-cgt-3.jpg"> <link href="https://cdn.jsdelivr.net/npm/remixicon@3.2.0/fonts/remixicon.css" rel="stylesheet"> <link rel="preconnect" href="https://fonts.googleapis.com"> <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin> <link href="https://fonts.googleapis.com/css2?family=Raleway:ital,wght@0,300;0,400;0,700;1,400;1,900&display=swap" rel="stylesheet"> <link rel="stylesheet" href="/build/app_manufacturingchemist.com.f649bd60.css"> <script src="/build/runtime.ced75ccf.js" defer></script><script src="/build/app_manufacturingchemist.com.47c00b06.js" defer></script> <script> document.addEventListener('DOMContentLoaded', function () { const cachedAdResponses = []; const lazyAdViewObserver = new IntersectionObserver(handleAdView, { threshold: [0.5] }); const lazyImageObserver = new IntersectionObserver(handleLazyImages, { threshold: 0.05 }); const lazyCSSBGImageObserver = new IntersectionObserver(handleLazyBGImages, { threshold: 0.05 }); // Initialize reloadAds(); observeImagesAndBG(); // Event listeners window.addEventListener('resize', reloadAds); document.querySelector('.nav-toggler').addEventListener('click', toggleNav); document.querySelector('.search-dropdown .close-btn').addEventListener('click', closeSearchDropdown); document.querySelectorAll('.has-sub a').forEach(element => { element.addEventListener('click', () => toggleSubMenu(element)); }); // Functions function reloadAds() { document.querySelectorAll('.ads > a').forEach(generateAdViewEvent); } function handleAdView(entries) { entries.forEach(entry => { if (entry.isIntersecting && entry.intersectionRatio > 0.5) { lazyAdViewObserver.unobserve(entry.target); confirmAdViewEvent(entry.target); } }); } function handleLazyImages(entries) { entries.forEach(entry => { if (entry.isIntersecting) { entry.target.childNodes.forEach(replacePictureSourceAndImgSets); lazyImageObserver.unobserve(entry.target); } }); } function handleLazyBGImages(entries) { entries.forEach(entry => { if (entry.isIntersecting) { const realImageUrl = entry.target.getAttribute('data-bg'); entry.target.style.backgroundImage = `url(${realImageUrl})`; lazyCSSBGImageObserver.unobserve(entry.target); } }); } function toggleNav() { const mainNavWrapper = document.querySelector('.main-nav-wrapper'); mainNavWrapper.classList.toggle('open'); this.classList.toggle('toggle-active'); } function closeSearchDropdown() { document.querySelector('.search-dropdown').classList.remove('open'); } function toggleSubMenu(element) { const parent = element.parentElement; const isOpen = parent.classList.toggle('open'); if (isOpen) { document.querySelectorAll('.has-sub').forEach(subElement => { if (subElement !== parent) subElement.classList.remove('open'); }); } } function generateAdViewEvent(element) { if (element.hasAttribute('data-is-loaded') || !element.dataset.url || !element.hasAttribute('data-is-mobile')) { return; } const uniqueId = element.getAttribute('data-unique-id'); if (uniqueId && cachedAdResponses[uniqueId]) { return; } if (element.hasAttribute('data-is-mobile')) { if ('1' === element.getAttribute('data-is-mobile') && !window.matchMedia("(max-width: 768px)").matches || '0' === element.getAttribute('data-is-mobile') && window.matchMedia("(max-width: 768px)").matches) { return; } } const xhr = new XMLHttpRequest(); xhr.onreadystatechange = function () { if (this.readyState === 4 && this.status === 200) { const data = JSON.parse(this.responseText); element.href = data.redirect_url; element.dataset.confirmUrl = data.confirm_url; lazyAdViewObserver.observe(element); element.setAttribute('data-is-loaded', 'true'); cachedAdResponses[uniqueId] = element; } }; xhr.open('POST', element.dataset.url, true); // ASynchronous request xhr.send(); } function confirmAdViewEvent(element) { if (element.dataset.confirmUrl) { const xhr = new XMLHttpRequest(); xhr.open('POST', element.dataset.confirmUrl, true); xhr.send(); } } function replacePictureSourceAndImgSets(element) { if (element.tagName === 'SOURCE') { element.srcset = element.dataset.srcset; delete element.dataset.srcset; } else if (element.tagName === 'IMG' && element.dataset.src) { element.src = element.dataset.src; delete element.dataset.src; } } function observeImagesAndBG() { document.querySelectorAll('picture').forEach(element => lazyImageObserver.observe(element)); document.querySelectorAll('[data-bg]').forEach(img => lazyCSSBGImageObserver.observe(img)); } }); </script> </head> <body>  <noscript> <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W9C8F5F" height="0" width="0" style="display:none;visibility:hidden"></iframe> </noscript>  <header class="header"> <div class="width-container wide"> <div class="padding"> <div class="header-top flex-mob-up align-items-center-mob-up justify-content-space-between-mob-up"> <a href="https://manufacturingchemist.com/" class="logo"> <img alt="Manufacturing Chemist" src="/images/logo.svg"/> </a> </div> <div class="header-bottom"> <nav class="main-nav-wrapper flex-sm-up align-items-center-sm-up justify-content-space-between-sm-up"> <button class="nav-toggler hide-show-sm-down" type="button" data-toggle="collapse" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"><span></span></span> </button> <ul class="main-nav"> <li><a href="/" style="margin-left:1rem;">Home</a></li> <li class="has-sub" style="margin-left:1rem;"><a href="#">Categories</a> <div class="dropdown wide"> <ul> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Ingredients" href="/tag/ingredients"><span itemprop="name">Ingredients</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Analysis" href="/tag/analysis"><span itemprop="name">Analysis</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Manufacturing" href="/tag/manufacturing"><span itemprop="name">Manufacturing</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Finance" href="/tag/finance"><span itemprop="name">Finance</span> <meta itemprop="position" content="1"> </a> </li> </ul> <ul> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Regulatory" href="/tag/regulatory"><span itemprop="name">Regulatory</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Drug Delivery" href="/tag/drug-delivery"><span itemprop="name">Drug Delivery</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Research & Development" href="/tag/research-and-development"><span itemprop="name">Research & Development</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Sustainability" href="/tag/sustainability"><span itemprop="name">Sustainability</span> <meta itemprop="position" content="1"> </a> </li> </ul> </div> </li> <li style="margin-left:1rem;"> <a title="Pharma 5.0" href="/tag/pharma">Pharma 5.0</a> </li> <li style="margin-left:1rem;"><a href="/jobs">Company News</a></li> <li style="margin-left:1rem;"><a href="/events">Events</a></li> <li style="margin-left:1rem;"><a title="Directory" href="/directory">Directory</a></li> <li class="has-sub search-dropdown" style="margin-left:1rem;"><a href="#"><i class="ri-search-line" aria-hidden="true" focusable="false"></i><span class="visually-hidden">Search</span></a> <div class="dropdown"> <ul> <li itemscope itemtype="https://schema.org/WebSite"> <meta itemprop="url" content="https://manufacturingchemist.com/"/> <form class="colourway02 transparent-background" method="get" action="/search" itemprop="potentialAction" itemscope itemtype="https://schema.org/SearchAction"> <div class="input-group"> <input type="search" id="q" name="q" data-autocomplete-url="/ajax" data-autocomplete-field="title" itemprop="query-input" placeholder="Enter search term" class="js-autocomplete form-control ui-autocomplete-input" aria-describedby="search-addon" autocomplete="off"> <meta itemprop="target" content="https://manufacturingchemist.com/search?q={q}"> <button class="icon-btn" type="submit" id="search-addon"> <i aria-hidden="true" focusable="false" class="ri-search-line ri-xl"></i> </button> </div> <span class="close-btn"><i aria-hidden="true" focusable="false" class="ri-close-line ri-xl"></i>Close search</span> </form> </li> </ul> </div> </ul> </nav> </div> </div> </div> </header> <nav class="breadcrumb"> <div class="width-container wide"> <ul id="wo-breadcrumbs" class="breadcrumb" itemscope itemtype="http://schema.org/BreadcrumbList"> <li><a href="/"><i class="ri-home-5-line" aria-hidden="true" focusable="false"></i><span class="visually-hidden">Home</span></a> </li> <li itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/tag/manufacturing" itemprop="item"> <span itemprop="name" class="current">Manufacturing</span> </a> <meta itemprop="position" content="1"/> </li> <li itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <span itemprop="name" class="current">Picking a CDMO as a CGT developer: what to consider and why</span> <meta itemprop="item" content="/charles-river-laboratories-picking-a-cdmo-as-a-cell-gene-therapy-developer"/> <meta itemprop="position" content="2"/> </li> </ul> </div> </nav> <div class="main"> <header class="article-header"> <div class="width-container wide"> <div class="padding"> <div class="grid flex-mob-row"> <div class="column06 flex-sm-up align-items-center-sm-up mob-order02"> <div class="article-intro"> <h1>Picking a CDMO as a CGT developer: what to consider and why </h1> <byline> Published: 30-Oct-2024 </byline> <byline class="tags-byline"> <div class="tags-background"> <a href="/tag/manufacturing">Manufacturing</a> <a href="/tag/research-and-development">Research & Development</a> <a href="/tag/cell-and-gene-therapy">Cell & Gene Therapy</a> </div> </byline> <p>Cell and gene therapy development and manufacture can be risky and highly complex, so biopharma companies would benefit from investing in a reliable and experienced CDMO</p> </div> </div> <div class="column06 mob-order01"> <div class="featured-image"> <div class="featured-image-inner article-featured-image " data-bg="/article-image-alias/picking-a-cdmo-as-a-cgt-3.jpg"> </div> </div> </div> </div> </div> </div> </header> <div class="width-container"> <div class="padding"> <div class="article-wrapper flex-md-up justify-content-space-between-md-up"> <article class="article"> <p></p> <p>Cell and gene therapies (CGTs) are rapidly gaining popularity as proof-of-concept data becomes available. This has resulted in an increase in the number of biotech companies that are investing in developing their own products. With five different cell and gene therapies gaining FDA approval in 2023 alone, there has been a steady influx of potentially life-changing treatments for patients with a wide range of disease indications.1</p> <p>Although cell and gene therapies may have the potential to revolutionise the pharmaceutical market, they are still relatively novel and come with unavoidable and complex challenges that must be overcome; these extend all the way from discovery to commercialisation. Therefore, outsourcing manufacturing has become increasingly appealing for CGT developers, who are beginning to outsource the process to contract development and manufacturing organisations (CDMOs). </p> <p>With so many CDMOs offering a range of services at different price points, quality levels and development timeframes, picking a suitable partner can be a daunting experience for any biopharma organisation — small or large. So, what makes a good CDMO? To find out, Annabel Kartal-Allen spoke with Andrew Frazer, Associate Director of Scientific Solutions at Charles River Laboratories.</p> <blockquote> <h2>Outsourcing can provide ... access to the best technologies without having to commit to buying bespoke equipment</h2> </blockquote> <h2><strong>Why use a CDMO?</strong></h2> <p>There are many steps involved in the commercialisation of a cell and gene therapy product, so getting one to market requires companies to surpass many milestones. Here are a few reasons why businesses should consider outsourcing their CGT operations.</p> <p><strong>The cost and associated risk of development/manufacture</strong>: There are many costs associated with the manufacture of cell and gene therapies — including raw materials, development costs and clinical trials, as well as testing and quality control. Small mistakes can have big impacts, so utilising an experienced CDMO to cover all these bases can save developers significantly in the long-run.</p> <p>To manufacture complex therapies such as CGTs in-house, companies must also have access to advanced, often specialist equipment. This can be a costly investment for pharmaceutical companies — many of which will not focus entirely on cell and gene therapies. Therefore, outsourcing can provide companies with access to the best technologies without having to commit to buying bespoke equipment.</p> <p><strong>Specialist expertise</strong>: Although CGTs haven’t been around for as long as small molecules or more traditional biologics, there is a growing base of field specialists, with many of them currently working in the CDMO space. Gaining insider know-how from specialist teams who have worked with a large number of CGT products can make a huge difference in terms of kick-starting a programme and getting the product to market as quickly and efficiently as possible. <img width="375" alt="Picking a CDMO as a CGT developer: what to consider and why" style="max-width:100%;display:inline-block;margin-bottom:1rem;float:right;margin:2rem;" src="/article-image-alias/picking-a-cdmo-as-a-cgt-2.jpg"></p> <p><strong>Production efficiency:</strong> As CDMOs often have extensive experience in their respective fields, they will have a more detailed understanding of associated development and manufacturing hurdles and how to mitigate them before they become major issues. An experienced CDMO will have the capability to reliably deliver with respect to cost, timelines, compliance, sustainability and yield. </p> <h2><br /> <strong>The perks of having one partner</strong></h2> <p>Although there are many CDMOs on the market who are able to serve clients in the cell and gene therapy market, development and manufacturing is just one piece of the puzzle, meaning that companies typically have to enter into and manage partnerships with multiple contractors to commercialise their therapeutic. Because of this, Andrew advises companies to find a partner with expertise in all stages of the CGT development process.</p> <p>According to Andrew, a big differentiator between a good and a great CDMO is their ability to offer an end-to-end service: “Having a CDMO on side that has a strong history in discovery, safety assessment and testing — as well as manufacturing solutions — creates efficiencies and can add significant value to the partnership.”</p> <p>“At Charles River, we have developed extensive capabilities in contract development and manufacturing, complimenting the success of our development and safety assessment services. This allows customers to select a provider that can support them through their full product life-cycle, rather than having to manage multiple partnerships.”</p> <blockquote> <h2>A key consideration ... is a CDMO’s ability to support analytical development, while also offering an established suite of quality control testing</h2> </blockquote> <h2><strong>Considering early stage manufacturing </strong></h2> <p>Production of representative and compliant materials is a key element involved in the overall success of a therapeutic product. “Typically, developers won’t want to invest heavily — particularly at the early stages — to generate compliant materials for use in preclinical development or early stage clinical trials,” states Andrew. “That’s why many choose to outsource this aspect of the CGT development process — with the potential to then move operations back in-house post-approval. A CDMO is there as a specialist manufacturer with a full range of capabilities and production scales that a drug developer wouldn’t necessarily have.”</p> <p>Having proven and compliant manufacturing platforms, as well as testing for plasmid and viral vector production ready to incorporate into your model can speed up the process by avoiding laborious development times.” Andrew says. </p> <p> </p> <h2><strong>Incorporating analytics</strong></h2> <p>There are many elements to the cell and gene therapy manufacturing process. One key consideration, Andrew notes, is a CDMO’s “ability to support analytical development while also offering an established suite of quality control testing to support development and manufacturing activities.” A previous article from Manufacturing Chemist highlighted the importance of developing potency assays early on in the process, so companies would be wise to find a CDMO who can assist them with this.<sup>2</sup> <img width="375" alt="Picking a CDMO as a CGT developer: what to consider and why" style="max-width:100%;display:inline-block;margin-bottom:1rem;float:right;margin:2rem;" src="/article-image-alias/picking-a-cdmo-as-a-cgt.jpg"></p> <p>"With the majority of CDMOs outsourcing analytics, finding a partner with fully in-house analytical testing capabilities can save time, money and effort,” Andrew emphasises. “When another level of complexity is added to the development chain, it can cause a bottleneck in the speed of manufacture and create major challenges with scheduling for complex programmes. It also requires a developer to place their faith in a company they may not directly interact with. By working with a single provider for manufacture and testing, developers have the opportunity to recognise more reliable timelines and reduce overall complexity and risk associated with manufacturing activities.” </p> <p> </p> <h2><strong>Building a relationship with your CDMO</strong></h2> <p>One of the most important aspects of a development and manufacturing collaboration is the relationship between a contractor and their client. By forming a close working relationship with your CDMO, you can ensure that all the processes in their remit are being conducted how you want them. Not only do you have better control of your therapeutic’s success, but you can also work with them to adapt and make changes if necessary — which is significantly easier if you’re on good terms.</p> <p>Andrew believes that companies should prioritise building relations: “Effective collaboration between a CDMO and a customer is incredibly important and anyone who’s entered into this type of activity will know that managing manufacturing activities — particularly if a number of separate companies are involved — can be particularly challenging.”</p> <p><p style='color:DarkSlateGray;margin:10px 80px 10px 80px;font-style:italic;border-style: hidden; border-top: 2px solid blue;border-bottom: 2px solid blue;'> Like this story? Subscribe to Manufacturing Chemist magazine for the latest news, updates and expert-written articles from the global pharmaceutical and biopharma sectors. For more information <a href='https://hpcimedia.com/service/signup-campaign/MCsub'> <font color="DarkSlateGray">click here. </font></a> </p> </p> <p>To overcome the logistical challenges of managing multiple CDMOs, Dr Frazer recommends that businesses aim to find a partner that can support all stages of the development journey. “By partnering with a CDMO with end-to-end capabilities, developers can have one point of contact and develop long-term relationships, helping them to reduce the organisational burden associated with managing the activities of multiple research, manufacturing and test sites.”</p> <p>“Developers have an extensive range of activities they’ll need to split their time and effort between. Simplifying outsourced activities like contract development and manufacturing can significantly reduce the labour burden while also creating opportunities for improved timelines and reduced risk.” </p> <p><br /> <span style="color:#3498db;"><strong>References</strong></span></p> <p><span style="color:#3498db;"><strong>1 </strong></span> www.nature.com/articles/s41587-024-02166-7.<br /> <span style="color:#3498db;"><strong>2 </strong></span> https://manufacturingchemist.com/why-potency-assays-are-a-crucial-consideration-for.</p> <p><br /> </p> <section class="article-footer"> <div class="social-share-nav"> <ul> <li><a href="https://twitter.com/manchempharma" target="blank" title="Follow Manufacturing Chemist on X"><i aria-hidden="true" focusable="false" class="circle-icon large x-icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"> <path d="M8 2H1L9.26086 13.0145L1.44995 21.9999H4.09998L10.4883 14.651L16 22H23L14.3917 10.5223L21.8001 2H19.1501L13.1643 8.88578L8 2ZM17 20L5 4H7L19 20H17Z"></path> </svg> </i><span class="visually-hidden">X</span></a></li> <li> <a href="https://www.linkedin.com/showcase/manufacturing-chemist/" target="blank" title="Follow Manufacturing Chemist on LinkedIn"><i aria-hidden="true" focusable="false" class="circle-icon large ri-linkedin-fill"></i><span class="visually-hidden">LinkedIn</span></a></li> </ul> </div> <div class="block block-companies large"> <div class="block-inner"> <div class="block-grid"> </div> <div class="seeAlso"> <ul> <li>Companies:</li> <li> Charles River Laboratories </li> </ul> </div> <a title="Directory" href="/directory"><span class="read-more arrow-link">See more</span></a> </div> </div> </section> </article> <sidebar class="sidebar"> <div class="block tip-trigger"> <h3 class="has-icon block-header"><i class=" ri-heart-line" aria-hidden="true" focusable="false"></i>You may also like</h3> <div class="block-inner"> <a href="/tag/manufacturing" class="category-label">Manufacturing</a> <a href="/leybold-launches-duradry-vacuum-pump-for-harsh-processes"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/leybold-launches-duradry-vacuum-pump-for.png"></div> </div> <h3>Leybold launches Duradry vacuum pump for harsh processes</h3> <span class="read-more arrow-link">Read more</span> <div class="tooltip">Advanced technology designed for reliability and efficiency </div> </a> </div> </div> <div class="block block-top-five"> <h3 class="has-icon block-header"><i class=" ri-arrow-right-up-line" aria-hidden="true" focusable="false"></i>Trending Articles</h3> <div class="block-inner"> <ol> <li> <div class="tip-trigger"> <a href="/sartorius-opens-bioprocess-innovation-centre-cell-gene-therapy-marlborough-us"> Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre <span class="tooltip">The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes </span> </a> </div> </li> <li> <div class="tip-trigger"> <a href="/imed-consultancy-helps-toby-orthopaedics-navigate-uk-regulations"> IMed Consultancy helps Toby Orthopaedics navigate UK regulations <span class="tooltip">Regulatory consultancy ensures compliance and confidence for Miami-based company </span> </a> </div> </li> <li> <div class="tip-trigger"> <a href="/aurobindo-pharma-signs-respiratory-drug-development-commercialisation-deal"> Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company <span class="tooltip">The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio </span> </a> </div> </li> </ol> </div> </div> <div class="block block-event"> <h3 class="has-icon block-header"><i class=" ri-calendar-close-line" aria-hidden="true" focusable="false"></i>Upcoming event</h3> <div class="block-inner"> <a href="/cphi-middle-east-and-africa-font-color-red-sup-i-postponed-i-sup-font--161475" class="block-inner event-block"> <span> <i class="ri-calendar-event-line ri-2x"></i> <h3>CPhI Middle East</h3> <byline>10–12 December 2024 | Conference | Riyadh, Saudi Arabia</byline> </span> </a> <a href="/events"><span class="read-more arrow-link">See all</span></a> </div> </div> </sidebar> </div> </div> </div> <script> document.addEventListener("DOMContentLoaded", function () { // Replace   in blockquote elements document.querySelectorAll("blockquote").forEach(function(blockquote) { blockquote.innerHTML = blockquote.innerHTML.replace(/ /g, ''); }); /* FitVids 1.1 - Vanilla JS version */ (function () { function fitVids(selector, options = {}) { const settings = { customSelector: options.customSelector || null, ignore: options.ignore || null, }; if (!document.getElementById("fit-vids-style")) { const css = ` .fluid-width-video-wrapper { width: 100%; position: relative; padding: 0; } .fluid-width-video-wrapper iframe, .fluid-width-video-wrapper object, .fluid-width-video-wrapper embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; } `; const style = document.createElement("style"); style.id = "fit-vids-style"; style.innerHTML = css; document.head.appendChild(style); } const selectors = [ 'iframe[src*="player.vimeo.com"]', 'iframe[src*="youtube.com"]', 'iframe[src*="youtube-nocookie.com"]', 'iframe[src*="kickstarter.com"][src*="video.html"]', 'object', 'embed', ]; if (settings.customSelector) { selectors.push(settings.customSelector); } const ignoreList = settings.ignore ? `.fitvidsignore, ${settings.ignore}` : ".fitvidsignore"; document.querySelectorAll(selector).forEach(function(element) { const videos = element.querySelectorAll(selectors.join(",")); videos.forEach(function(video) { if (video.closest(ignoreList)) return; if (video.tagName.toLowerCase() === "embed" && video.closest("object")) return; if (video.closest(".fluid-width-video-wrapper")) return; let height = video.tagName.toLowerCase() === "object" || !isNaN(parseInt(video.height)) ? parseInt(video.height) : video.clientHeight; let width = !isNaN(parseInt(video.width)) ? parseInt(video.width) : video.clientWidth; let aspectRatio = height / width; const wrapper = document.createElement("div"); wrapper.className = "fluid-width-video-wrapper"; wrapper.style.paddingTop = (aspectRatio * 100) + "%"; video.parentNode.insertBefore(wrapper, video); wrapper.appendChild(video); video.removeAttribute("height"); video.removeAttribute("width"); }); }); } // Initialize FitVids on ".main" selector fitVids(".main"); // Script for ad insertion based on article length and children count const regex = /(<([^>]+)>|\r\n|\n|\r)/ig; const primaryAd = document.querySelector('.mobile-ad-01')?.innerHTML || ''; const secondaryAd = document.querySelector('.mobile-ad-02')?.innerHTML || ''; const tertiaryAd = document.querySelector('.mobile-ad-03')?.innerHTML || ''; const articleHeaderHeight = document.querySelector('.header')?.offsetHeight || 0; const articleContentHeight = document.querySelector('.article-header')?.offsetHeight + document.querySelector('.article')?.offsetHeight || 0; const article = document.querySelector('.article')?.textContent || ''; const articleChildrenCount = document.querySelector('.article')?.children.length || 0; const articleCharCount = article.replace(regex, "").length; let childCount = 1; if (articleCharCount > 2000 && articleChildrenCount >= 10) { Array.from(document.querySelector('.article').children).forEach(function(para) { const position = para.getBoundingClientRect().top; if (childCount === 3) para.insertAdjacentHTML("afterend", primaryAd); if (childCount === 7) para.insertAdjacentHTML("afterend", secondaryAd); if (childCount === articleChildrenCount) para.insertAdjacentHTML("beforebegin", tertiaryAd); childCount++; }); } })(); }); </script> <section class="you-may-also-like"> <h2 class="span-header"><span>You may also like</span></h2> <div class="width-container wide"> <div class="padding"> <div class="fixed-grid"> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/manufacturing" class="category-label">Manufacturing</a> <a href="/leybold-launches-duradry-vacuum-pump-for-harsh-processes"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/leybold-launches-duradry-vacuum-pump-for.png"></div> </div> <h3>Leybold launches Duradry vacuum pump for harsh processes</h3> <div class="tooltip above">Advanced technology designed for reliability and efficiency </div>  </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/distribution" class="category-label">Distribution</a> <a href="/2bscientific-expands-life-science-product-supply-munich-germany-facility"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/2bscientific-expands-its-life-science-product.png"></div> </div> <h3>2BScientific expands its life science product supply service to Europe with new German facility</h3> <div class="tooltip above">The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies </div>  </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/digital" class="category-label">Digital</a> <a href="/cellular-origins-why-cell-gene-therapy-manufacturers-should-automate-the-production-process"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/why-cgt-manufacturers-should-automate-the-2.png"></div> </div> <h3>Why CGT manufacturers should automate the production process</h3> <div class="tooltip above">Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient </div>  </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/manufacturing" class="category-label">Manufacturing</a> <a href="/anton-paar-expands-litesizer-dia-series-with-new"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/anton-paar-expands-litesizer-dia-series.png"></div> </div> <h3>Anton Paar expands Litesizer DIA Series with new models</h3> <div class="tooltip above">Introducing affordable and advanced solutions for particle analysis </div>  </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/manufacturing" class="category-label">Manufacturing</a> <a href="/triple-your-efficiency-with-the-new-drysyn-vortex"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/triple-your-efficiency-with-the-new.png"></div> </div> <h3>Triple your efficiency with the new DrySyn Vortex</h3> <div class="tooltip above">Boost productivity with temperature-controlled parallel reactions </div>  </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/manufacturing" class="category-label">Manufacturing</a> <a href="/five-critical-design-elements-for-pelton-wheel-turbine"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/five-critical-design-elements-for-pelton.png"></div> </div> <h3>Five critical design elements for Pelton wheel turbine flowmeters</h3> <div class="tooltip above">Titan Enterprises outlines the factors for cost-effective and reliable low-flow measurement </div>  </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/manufacturing" class="category-label">Manufacturing</a> <a href="/automated-feeding-a-scalable-affordable-solution-to-low"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/automated-feeding-a-scalable-affordable-solution.jpg"></div> </div> <h3>Automated feeding: a scalable, affordable solution to low manufacturing productivity</h3> <div class="tooltip above">In the UK, productivity is languishing and workforce shortages are significant. No sector understands this more than manufacturing, which had a staggering 74,000 vacancies in 2023, contributing to the increasing cost of production </div>  </a> </div> </div> <div class="block height01"> <a href="https://hpcimedia.com/service/signup-campaign/MCeNews" class="btn">Subscribe now</a> </div> </div> </div> </div> </section> </div> <footer class="footer colourway02"> <div class="footer-section"> <div class="width-container wide"> <div class="padding"> <div class="grid noSubscribe"> <div class="column04"> <div class="block"> <h3 class="has-icon block-header"><i aria-hidden="true" focusable="false" class="ri-mail-line"></i>Get our newsletter</h3> <div class="input-group"> <input type="email" placeholder="Enter your email address" required> <button class="icon-btn" type="submit" id="search-addon" onclick="location.href='https://hpcimedia.com/service/signup-campaign/MCeNews?email=' + this.previousElementSibling.value"> <i class="ri-arrow-right-line ri-xl"></i> </button> </div> </div> </div> <div class="column04"> <div class="block"> <h3 class="has-icon block-header"><i aria-hidden="true" focusable="false" class="ri-share-line"></i>Follow us</h3> <div class="social-nav large"> <ul> <li> <a href="https://twitter.com/manchempharma" target="blank" title="Follow Manufacturing Chemist on X"><i aria-hidden="true" focusable="false" class="x-icon ri-2x"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"> <path d="M8 2H1L9.26086 13.0145L1.44995 21.9999H4.09998L10.4883 14.651L16 22H23L14.3917 10.5223L21.8001 2H19.1501L13.1643 8.88578L8 2ZM17 20L5 4H7L19 20H17Z"></path> </svg> </i><span class="visually-hidden">X</span></a></li> <li> <a href="https://www.linkedin.com/showcase/manufacturing-chemist/" target="blank" title="Follow Manufacturing Chemist on LinkedIn"><i aria-hidden="true" focusable="false" class="ri-linkedin-fill ri-2x"></i><span class="visually-hidden">LinkedIn</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </div> <div class="footer-section"> <div class="width-container wide"> <div class="padding"> <div class="grid"> <div class="column04"> <div class="logo"><img src="/images/logo.svg"/></div> </div> <div class="column08"> <div class="footer-links-wrapper grid"> <div class="column04"> <ul class="footer-links"> <li> <a href="https://hpcimedia.com/manufacturing-chemist/">About Manufacturing Chemist</a> </li> <li><a href="https://hpcimedia.com/">About HPCi Media</a></li> <li> <a href="https://hpcimedia.com/service/signup-campaign/MCeNews">Newsletter sign up</a></li> <li><a href="https://hpcimedia.com/">Contact Us</a></li> </ul> </div> <div class="column04"> <ul class="footer-links"> <li><a href="https://hpcimedia.com/manufacturing-chemist/">Advertise</a></li> <li><a href="https://hpcimedia.com/tsandcs/">Terms and Conditions</a></li> <li><a href="https://hpcimedia.com/privacy-policy/">Privacy</a></li> </ul> </div> <div class="column04"> <small>© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company</small> </div> </div> </div> </div> </div> </div> </div> </footer></body> </html>

CINXE.COM

Picking a CDMO as a CGT developer: what to consider and why